XBIT XBiotech Inc. - Common Stock
$2,26
Prix · Aoû 19, 2026
Données fondamentales au Aoû 13, 2026
Fourchette 52 semaines
$2–$4
11% of range
Note des analystes
BUY
7 analysts
Objectif de cours
—
P/E (TTM)
-1.6
ROE
—
Marge nette
—
XBIT Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$2.26
Capitalisation Boursière
—
P/E (TTM)
-1.6
BPA (TTM)
$-1.49
Revenus (TTM)
$0
Rendement div.
—
ROE
—
Dette/Capitaux propres
—
Fourchette 52 semaines
$2 – $4
XBIT Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$0
2018-12-31
→
2023-12-31
BPA
$-1.49
2017-12-31
→
2025-12-31
Flux de trésorerie libre
—
2016-12-31
→
2022-12-31
Marges
—
2020-12-31
→
2022-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
XBIT
Médiane des pairs
P/E (TTM)
-1.6
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
XBIT
Médiane des pairs
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
XBIT
Médiane des pairs
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
XBIT
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
XBIT
Médiane des pairs
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
Rendement du Dividende
—
Ratio de distribution
—
CAGR des dividendes sur 5 ans
—
| Date ex-dividende | Montant |
|---|---|
| 15 juillet 2021 | $2,5000 |
XBIT Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
7 analystes
- Achat fort 2 28,6%
- Achat 4 57,1%
- Conserver 1 14,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
3.7%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2020 | $0.00 | $0.06 | -0.06% |
| 31 décembre 2019 | $14.59 | $-0.15 | 14.7% |
| 30 septembre 2019 | $-0.15 | $-0.15 | 0.00% |
| 30 juin 2019 | $-0.16 | $-0.15 | -0.01% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| XBIT | — | -1.6 | — | — | — | — |
| ELTX | — | -3.1 | — | — | — | — |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | — |
| IBIO | $15M | -0.4 | 77.8% | -4594.2% | -101.5% | — |
| CYPH | $97M | 16.6 | — | — | 6.1% | — |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| RNTX | — | -0.6 | — | — | — | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| DWTX | $124M | -0.6 | 123.6% | — | -83.8% | — |
| RNXT | — | -2.6 | 2511.6% | — | — | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $4M | $18M | $44M | $0 | $0 | |
| Cost of Revenue | · | · | $0 | $651.0K | $6M | $35M | $0 | $0 | |
| Gross Profit | · | · | $0 | $3M | $13M | $9M | $0 | $0 | |
| R&D Expense | $47M | $38M | $33M | $32M | $28M | $10M | $24M | $16M | |
| SG&A Expense | $8M | $5M | $5M | $6M | $9M | $18M | $7M | $5M | |
| Operating Expenses | · | $42M | $38M | $38M | $38M | $28M | $31M | $21M | |
| Operating Income | $-56M | $-42M | $-38M | $-34M | $-25M | $-18M | $-31M | $-21M | |
| Other Non-op | $1M | $432.0K | $883.0K | $-121.0K | $-132.0K | $-503.0K | $10.0K | $4.0K | |
| Pretax Income | $-45M | $-39M | $-24M | $-34M | $-25M | $-13M | $718M | $-21M | |
| Income Tax | $235.0K | $-32.0K | $244.0K | $-688.0K | $-8M | $-2M | $50M | $0 | |
| Net Income | $-46M | $-39M | $-25M | $-33M | $-17M | $-11M | $669M | $-21M | |
| EPS (Basic) | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 | $-0.36 | $17.17 | $-0.59 | |
| EPS (Diluted) | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 | $-0.36 | $14.44 | $-0.59 | |
| Shares (Basic) | 30,487,731 | 30,460,980 | 30,438,459 | 30,439,275 | 30,043,380 | 30,823,458 | 38,945,468 | 35,804,304 | |
| Shares (Diluted) | 30,487,731 | 30,460,980 | 30,438,459 | 30,439,275 | 30,043,380 | 30,823,458 | 46,319,457 | 35,804,304 | |
| EBITDA | · | · | · | $-34M | $-25M | $-18M | $-31M | $-21M |
Bilan 19
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $126M | $173M | $200M | $157M | $237M | $237M | $715M | $16M | |
| Short-term Investments | · | · | $0 | $60M | $0 | · | · | · | |
| Receivables | · | $700.0K | $860.0K | $1M | $0 | $4M | $0 | · | |
| Prepaid Expense | $1M | $1M | $760.0K | $601.0K | $934.0K | $582.0K | $2M | $1M | |
| Current Assets | $127M | $175M | $202M | $220M | $247M | $326M | $716M | $17M | |
| PP&E (Net) | $23M | $25M | $25M | $26M | $28M | $27M | $25M | $27M | |
| Accum. Depreciation | · | $22M | $20M | $16M | $16M | $13M | $12M | $9M | |
| Total Assets | $150M | $199M | $227M | $246M | $275M | $354M | $817M | $44M | |
| Accounts Payable | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | $6M | $3M | $4M | $2M | $1M | $1M | $4M | $1M | |
| Current Liabilities | $8M | $15M | $6M | $4M | $3M | $4M | $60M | $3M | |
| Deferred Tax | $5.0K | $0 | $0 | $59.0K | $873.0K | $0 | · | · | |
| Total Liabilities | $10M | $17M | $8M | $6M | $6M | $5M | $61M | $3M | |
| Common Stock | $277M | $273M | $271M | $267M | $262M | $250M | $325M | $279M | |
| Retained Earnings | $-136M | $-91M | $-52M | $-28M | $5M | $98M | $431M | $-238M | |
| AOCI | · | · | $0 | $826.0K | $2M | $1M | $-106.0K | $-255.0K | |
| Stockholders' Equity | $140M | $182M | $219M | $240M | $269M | $349M | $756M | $41M | |
| Liabilities + Equity | $150M | $199M | $227M | $246M | $275M | $354M | $817M | $44M | |
| Shares Outstanding | 30,487,731 | 30,487,731 | 30,436,964 | 30,439,275 | 30,439,275 | 29,304,396 | 41,519,633 | 35,899,772 |
Flux de trésorerie 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $2M | $3M | $5M | $4M | $13M | $3M | $2M | |
| Deferred Tax | $5.0K | $0 | $-59.0K | $-816.0K | $1M | $-47.0K | $-13.0K | $0 | |
| Operating Cash Flow | $-40M | $-31M | $-19M | $-15M | $69M | $-65M | $-18M | $-17M | |
| CapEx | $289.0K | $1M | $362.0K | $585.0K | $4M | $4M | $204.0K | $122.0K | |
| Investing Cash Flow | $-289.0K | $-1M | $61M | $-64M | $-4M | $-4M | $675M | $-122.0K | |
| Stock Issued | · | · | $4.8K | · | $8M | $10M | $4M | · | |
| Stock Repurchased | · | $0 | $14.0K | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $8M | $10M | $4M | · | |
| Dividends Paid | · | · | · | $0 | $75M | $0 | $0 | · | |
| Financing Cash Flow | $-10M | $10M | $-9.0K | $0 | $-67M | $-410M | $42M | $201.0K | |
| Net Change in Cash | $-47M | $-27M | $43M | $-80M | $-383.0K | $-477M | $699M | $-16M | |
| Taxes Paid | $-81.0K | $87.0K | $141.0K | · | · | · | · | · | |
| Free Cash Flow | · | · | · | $-15M | $66M | $-69M | $-18M | $-17M |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 83.8% | 68.4% | 21.5% | · | · | |
| Operating Margin | · | · | · | -860.1% | -136.4% | -41.5% | · | · | |
| Net Margin | · | · | · | -820.4% | -94.7% | -25.5% | · | · | |
| Pretax Margin | · | · | · | -837.6% | -138.4% | -29.1% | · | · | |
| EBITDA Margin | · | · | · | -860.1% | -136.4% | -41.5% | · | · | |
| ROA | · | · | · | -12.6% | -5.5% | -1.9% | 155.3% | -39.4% | |
| ROE | · | · | · | -13.6% | -6.4% | -3.2% | 163.0% | -47.9% | |
| ROIC | · | · | · | -14.1% | -6.4% | -4.6% | -3.9% | -50.7% |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | 54.1 | 71.5 | 81.8 | 11.9 | 5.8 | |
| Quick Ratio | · | · | · | 53.5 | 68.6 | 60.6 | 11.9 | 5.4 |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | · | · | · | · | 8.9 | 21.4 | · | · |
Taux de croissance 1
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -78.2% | -58.2% | · | · | · |
Valorisation (TTM) 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $0 | $4M | $18M | $44M | $0 | $0 | |
| Net Income TTM | $-46M | $-39M | $-25M | $-33M | $-17M | $-11M | $669M | $-21M | |
| Market Cap | · | · | · | $107M | $339M | $459M | $775M | $182M | |
| P/E | -1.6 | -3.1 | -4.9 | -3.2 | -19.2 | -43.5 | 1.3 | -8.6 | |
| P/S | · | · | · | 26.6 | 18.4 | 10.4 | · | · | |
| P/B | · | · | · | 0.4 | 1.3 | 1.3 | 1.0 | 4.4 | |
| P / Tangible Book | 0.5 | 0.7 | 0.6 | 0.4 | 1.3 | 1.3 | · | · | |
| P / Cash Flow | · | · | · | -7.2 | 4.9 | -7.0 | -42.4 | -11.0 | |
| P / FCF | · | · | · | -6.9 | 5.1 | -6.7 | -41.9 | -10.9 | |
| Dividend Yield | · | · | · | 0.00% | 22.1% | 0.00% | 0.00% | · | |
| Earnings Yield | -62.3% | -31.9% | -20.2% | -30.8% | -5.2% | -2.3% | 77.4% | -11.6% | |
| Payout Ratio | · | · | · | 0.00% | -430.7% | · | · | · | |
| Annual Payout | · | · | · | $0 | $75M | $0 | $0 | · |
Compte de résultat 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $300.0K | $2M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $16.0K | $215.0K | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $284.0K | $1M | |
| R&D Expense | $5M | $5M | $25M | $5M | $5M | $12M | $8M | $7M | $13M | $10M | $8M | $8M | $11M | $6M | $7M | $7M | |
| SG&A Expense | $850.0K | $1M | $4M | $967.0K | $1M | $2M | $927.0K | $777.0K | $2M | $1M | $782.0K | $973.0K | $2M | $915.0K | $1M | $840.0K | |
| Operating Expenses | $6M | · | · | $6M | $6M | $14M | $9M | $8M | $15M | $11M | $9M | $9M | $13M | $7M | $8M | $8M | |
| Operating Income | $-6M | $-6M | $-30M | $-6M | $-6M | $-14M | $-9M | $-8M | $-15M | $-11M | $-9M | $-9M | $-13M | $-7M | $-8M | $-6M | |
| Other Non-op | $-9.0K | $1M | $549.0K | $-85.0K | $-3.0K | $995.0K | $407.0K | $25.0K | $0 | $0 | $3.0K | $0 | $750.0K | $130.0K | $-2.0K | $0 | |
| Pretax Income | $-7M | $-5M | $-27M | $-6M | $-2M | $-11M | $-11M | $-5M | $-13M | $-10M | $-5M | $-7M | $-9M | $-4M | $-3M | $-10M | |
| Income Tax | $46.0K | $49.0K | $76.0K | $102.0K | $28.0K | $29.0K | $-41.0K | $9.0K | $-25.0K | $25.0K | $-172.0K | $308.0K | $71.0K | $37.0K | $578.0K | $2M | |
| Net Income | $-7M | $-6M | $-27M | $-6M | $-2M | $-11M | $-11M | $-5M | $-13M | $-10M | $-5M | $-7M | $-9M | $-4M | $-3M | $-13M | |
| EPS (Basic) | $-0.22 | $-0.18 | $-0.87 | $-0.20 | $-0.06 | $-0.36 | $-0.34 | $-0.16 | $-0.43 | $-0.33 | $-0.15 | $-0.24 | $-0.29 | $-0.13 | $-0.10 | $-0.42 | |
| Shares (Basic) | 30,487,731 | 30,487,731 | -60,975,462 | 30,487,731 | 30,487,731 | 30,487,731 | -60,911,651 | 30,472,557 | 30,456,101 | 30,443,973 | -60,876,572 | 30,436,638 | 30,439,118 | 30,439,275 | -60,878,554 | 30,439,277 | |
| EBITDA | $-6M | $-6M | · | $-6M | $-6M | $-14M | · | $-8M | $-15M | $-11M | · | $-9M | $-13M | $-7M | · | $-6M |
Bilan 19
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $115M | $126M | $147M | $153M | $156M | $173M | $183M | $189M | $201M | $200M | $202M | $143M | $152M | $157M | $161M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $0 | $61M | $60M | $60M | $60M | |
| Receivables | · | · | · | $450.0K | $480.0K | $480.0K | · | $730.0K | $870.0K | $870.0K | · | $881.0K | · | · | · | $2M | |
| Prepaid Expense | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $760.0K | $879.0K | $947.0K | $703.0K | $601.0K | $621.0K | |
| Current Assets | $111M | $117M | $127M | $149M | $155M | $158M | $175M | $185M | $191M | $203M | $202M | $204M | $210M | $216M | $220M | $223M | |
| PP&E (Net) | $22M | $23M | $23M | $23M | $24M | $24M | $25M | $25M | $25M | $25M | $25M | $25M | $26M | $26M | $26M | $27M | |
| Accum. Depreciation | · | · | · | · | · | · | $22M | · | · | · | $18M | · | · | · | $16M | · | |
| Total Assets | $134M | $140M | $150M | $172M | $179M | $182M | $199M | $210M | $216M | $228M | $227M | $230M | $235M | $242M | $246M | $251M | |
| Accounts Payable | $1M | $857.0K | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $1M | $2M | $1M | $2M | $1M | |
| Accrued Liabilities | $2M | $2M | $6M | $2M | $2M | $4M | $3M | $4M | $5M | $4M | $4M | $4M | $3M | $2M | $2M | $2M | |
| Current Liabilities | $3M | $3M | $8M | $4M | $4M | $5M | $15M | $16M | $17M | $17M | $6M | $5M | $4M | $4M | $4M | $4M | |
| Deferred Tax | $5.0K | $5.0K | $5.0K | · | · | · | $0 | · | · | · | · | $0 | $0 | $0 | $59.0K | $872.0K | |
| Total Liabilities | $5M | $5M | $10M | $5M | $6M | $7M | $17M | $18M | $19M | $19M | $8M | $7M | $6M | $5M | $6M | $6M | |
| Common Stock | $277M | $277M | $277M | $277M | $277M | $276M | $273M | $272M | $272M | $272M | $271M | $270M | $269M | $268M | $267M | $266M | |
| Retained Earnings | $-149M | $-142M | $-136M | $-109M | $-103M | $-102M | $-91M | $-80M | $-75M | $-62M | $-52M | $-48M | $-40M | $-32M | $-28M | $-25M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $440.0K | $440.0K | $440.0K | $826.0K | $3M | |
| Stockholders' Equity | $128M | $135M | $140M | $167M | $173M | $175M | $182M | $192M | $197M | $209M | $219M | $223M | $229M | $237M | $240M | $245M | |
| Liabilities + Equity | $134M | $140M | $150M | $172M | $179M | $182M | $199M | $210M | $216M | $228M | $227M | $230M | $235M | $242M | $246M | $251M | |
| Shares Outstanding | 30,487,731 | 30,487,731 | 30,487,731 | 30,487,731 | 30,487,731 | 30,487,731 | 30,487,731 | 30,479,406 | 30,463,156 | 30,450,881 | 30,436,964 | 30,436,964 | 30,435,714 | 30,439,275 | 30,439,275 | 30,439,277 |
Flux de trésorerie 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $172.0K | $172.0K | $162.0K | $24.0K | $107.0K | $3M | $628.0K | $365.0K | $379.0K | $381.0K | $688.0K | $955.0K | $914.0K | $705.0K | $1M | $1M | |
| Operating Cash Flow | $-5M | $-9M | $-23M | $-4M | $-6M | $-7M | $-7M | $-6M | $-11M | $-7M | $-3M | $-1M | $-9M | $-5M | $-3M | $-160.0K | |
| CapEx | $0 | $0 | $34.0K | $110.0K | $51.0K | $94.0K | $84.0K | $338.0K | $627.0K | $255.0K | $115.0K | $33.0K | $208.0K | $6.0K | $132.0K | $210.0K | |
| Investing Cash Flow | $-4.0K | $9.0K | $-34.0K | $-110.0K | $-51.0K | $-94.0K | $-84.0K | $-338.0K | $-627.0K | $-255.0K | $-115.0K | $62M | $-208.0K | $-6.0K | $-4M | $-60M | |
| Stock Issued | · | · | · | · | · | · | · | $64.0K | $48.0K | $55.0K | · | · | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $55.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $0 | $0 | $0 | $0 | $-10M | $283.0K | $64.0K | $48.0K | $10M | $0 | $5.0K | $-14.0K | $0 | $0 | $0 | |
| Net Change in Cash | $-6M | $-10M | $-22M | $-6M | $-3M | $-17M | $-10M | $-5M | $-13M | $1M | $-2M | $59M | $-9M | $-5M | $-3M | $-65M | |
| Free Cash Flow | · | $-9M | · | · | · | $-7M | · | · | · | $-7M | · | · | · | $-5M | · | · |
Rentabilité 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 87.2% | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -380.3% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -753.5% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -610.5% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -380.3% | |
| ROA | -4.3% | -3.4% | · | -3.1% | -0.89% | -5.3% | · | -2.3% | -5.8% | -4.3% | · | -3.1% | -3.5% | -1.5% | · | -4.8% | |
| ROE | -4.5% | -3.5% | · | -3.4% | -0.95% | -5.7% | · | -2.4% | -6.1% | -4.5% | · | -3.1% | -3.6% | -1.5% | · | -4.9% | |
| ROIC | -4.8% | -4.7% | · | -3.7% | -3.7% | -7.8% | · | -4.1% | -7.6% | -5.2% | · | -4.0% | -5.8% | -3.0% | · | -3.2% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 33.2 | 39.0 | · | 41.8 | 40.2 | 29.1 | · | 11.6 | 11.1 | 12.0 | · | 38.6 | 47.1 | 59.8 | · | 62.4 | |
| Quick Ratio | 32.7 | 38.5 | · | 41.5 | 39.8 | 28.9 | · | 11.5 | 11.1 | 12.0 | · | 38.4 | 46.0 | 58.8 | · | 61.9 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 2.1 |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $3M | $4M | · | $8M | |
| Net Income TTM | $-20M | $-24M | · | $-24M | $-31M | $-39M | · | $-33M | $-35M | $-31M | · | $-23M | $-28M | $-31M | · | $-36M | |
| Market Cap | $70M | $72M | · | $81M | $91M | $99M | · | $236M | $157M | $248M | · | $125M | $181M | $105M | · | $110M | |
| P/E | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.5 | 0.4 | 0.6 | · | 0.3 | 0.4 | 0.2 | · | 0.3 | |
| P/S | 41.7 | 42.6 | · | 48.3 | 53.9 | 58.8 | · | 140.2 | 93.2 | 147.4 | · | 74.6 | 56.3 | 28.3 | · | 13.4 | |
| P/B | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 1.2 | 0.8 | 1.2 | · | 0.6 | 0.8 | 0.4 | · | 0.5 | |
| P / Tangible Book | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 1.2 | 0.8 | 1.2 | · | 0.6 | 0.8 | 0.4 | · | 0.5 | |
| P / Cash Flow | · | -8.0 | · | · | · | -14.7 | · | · | · | -34.4 | · | · | · | -21.8 | · | · | |
| P / FCF | · | -8.0 | · | · | · | -14.5 | · | · | · | -33.2 | · | · | · | -21.8 | · | · | |
| Earnings Yield | 623.9% | 610.6% | · | 539.5% | 483.2% | 442.9% | · | 185.6% | 279.2% | 176.5% | · | 348.3% | 241.6% | 415.9% | · | 396.4% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | — | — | $0 | $4M | $18M |
| Marge Brute % | — | — | — | 83.8% | 68.4% |
| Marge d'exploitation % | — | — | — | -860.1% | -136.4% |
| Résultat net | $-46M | $-39M | $-25M | $-33M | $-17M |
| BPA dilué | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | — | — | — | 54.1 | 71.5 |
| Ratio de liquidité réduite | — | — | — | 53.5 | 68.6 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | — | — | — | $-15M | $66M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 47 déclarants · $4.1M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 8 (+4 vs T. préc.) | 3 (-5 vs T. préc.) | 4 (-2 vs T. préc.) | 10 (-1 vs T. préc.) | +462K |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $460 419 | 200 182 | 11,15% | Actions |
| RBF Capital, LLC | $456 552 | 198 501 | 11,06% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $399 019 | 173 361 | 9,66% | Actions |
| MORGAN STANLEY | $338 015 | 146 963 | 8,19% | Actions |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $226 428 | 98 447 | 5,48% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $212 440 | 92 365 | 5,15% | Actions |
| MILLENNIUM MANAGEMENT LLC | $182 459 | 79 330 | 4,42% | Actions |
| JANE STREET GROUP, LLC | $171 810 | 74 700 | 4,16% | Option d'achat |
| STATE STREET CORP | $167 914 | 73 006 | 4,07% | Actions |
| Empowered Funds, LLC | $136 958 | 59 547 | 3,32% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $101 200 | 44 000 | 2,45% | Option de vente |
| Nuveen Asset Management, LLC | $98 272 | 24 879 | 2,38% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $95 825 | 41 663 | 2,32% | Actions |
| Bank of New York Mellon Corp | $86 018 | 37 399 | 2,08% | Actions |
| Squarepoint Ops LLC | $79 941 | 34 757 | 1,94% | Actions |
| Qube Research & Technologies Ltd | $77 211 | 33 570 | 1,87% | Actions |
| BlackRock, Inc. | $69 681 | 30 296 | 1,69% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $68 770 | 29 900 | 1,67% | Option d'achat |
| CITADEL ADVISORS LLC | $67 142 | 29 192 | 1,63% | Actions |
| NORTHERN TRUST CORP | $65 585 | 28 515 | 1,59% | Actions |
| Connor, Clark & Lunn Investment Management Ltd. | $64 269 | 27 943 | 1,56% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $60 867 | 26 464 | 1,47% | Actions |
| NATIONAL BANK OF CANADA /FI/ | $57 500 | 25 000 | 1,39% | Actions |
| BANK OF AMERICA CORP /DE/ | $54 715 | 23 789 | 1,33% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $49 036 | 21 320 | 1,19% | Actions |
| AMERICAN CENTURY COMPANIES INC | $42 276 | 18 381 | 1,02% | Actions |
| TWO SIGMA ADVISERS, LP | $38 957 | 16 300 | 0,94% | Actions |
| SYNOVUS FINANCIAL CORP | $31 377 | 11 796 | 0,76% | Actions |
| Thomasville National Bank | $30 705 | 13 350 | 0,74% | Actions |
| XTX Topco Ltd | $30 084 | 13 080 | 0,73% | Actions |
| Pinnacle Financial Partners, Inc. | $27 131 | 11 796 | 0,66% | Actions |
| Point72 Asia (Singapore) Pte. Ltd. | $18 133 | 6 817 | 0,44% | Actions |
| VANGUARD GROUP INC | $16 752 | 7 009 | 0,41% | Actions |
| Vanguard Global Advisers, LLC | $16 121 | 7 009 | 0,39% | Actions |
| Cubist Systematic Strategies, LLC | $14 151 | 5 320 | 0,34% | Actions |
| UBS Group AG | $11 581 | 5 035 | 0,28% | Actions |
| McIlrath & Eck, LLC | $1 770 | 753 | 0,04% | Actions |
| JONES FINANCIAL COMPANIES LLLP | $862 | 370 | 0,02% | Actions |
| JPMORGAN CHASE & CO | $224 | 96 | 0,01% | Actions |
| BARCLAYS PLC | $216 | 94 | 0,01% | Actions |
| SBI Securities Co., Ltd. | $85 | 37 | 0,00% | Actions |
| GSA CAPITAL PARTNERS LLP | $71 | 30 654 | 0,00% | Actions |
| Larson Financial Group LLC | $48 | 21 | 0,00% | Actions |
| CWM, LLC | $31 | 13 | 0,00% | Actions |
| Caitong International Asset Management Co., Ltd | $25 | 11 | 0,00% | Actions |
| JANE STREET GROUP, LLC | $2 | 1 | 0,00% | Actions |
| ROYAL BANK OF CANADA | $0 | 74 | 0,00% | Actions |
Initiés de la société 23 initiés · 10 dirigeants · 11 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| John Simard | Chief Executive Officer | 17 mars 2025 A | 3 823 166 | 0 | 0 | $0 |
| James Scott Whitehurst | Chief Financial Officer | 2 mai 2016 A | — | 0 | 0 | $0 |
| Sushma Shivaswamy | Chief Scientific Officer | 10 février 2023 A | 0 | 0 | 0 | $0 |
| Queena Han | VP Finance & HR | 19 novembre 2021 A | 57 692 | 0 | 0 | $0 |
| Benjamin Guzman | Sr.VP Corp. Strategy & Finance | 7 juillet 2017 A | — | 0 | 0 | $0 |
| Michael Stecher | Medical Director | 19 juin 2017 M | — | 0 | 0 | $0 |
| Trey Benson | VP of Commercial Development | 20 juin 2016 A | — | 0 | 0 | $0 |
| Dawn Mccollough | VP Clinical Operations | 16 mai 2016 A | — | 0 | 0 | $0 |
| Kalidip Choudhury | VP of Business Development | 14 décembre 2015 M | — | 0 | 0 | $0 |
| Kelly Thornburg | SVP of Operations | 8 juin 2015 A | — | 0 | 0 | $0 |
| David Spencer Soffer | Administrateur | 1 octobre 2025 A | — | 0 | 0 | $0 |
| Thomas Martin Kuendig | Administrateur | 1 octobre 2025 A | — | 0 | 0 | $0 |
| Tevi David Troy | Administrateur | 1 octobre 2025 A | — | 0 | 0 | $0 |
| Craig Evan Rademaker | Administrateur | 1 octobre 2025 A | — | 0 | 0 | $0 |
| Peter Libby | Administrateur | 20 juin 2024 A | — | 0 | 0 | $0 |
| Donald H. Macadam | Administrateur | 20 juin 2024 A | 10 000 | 0 | 0 | $0 |
| Jan-Paul Waldin | Administrateur | 20 juin 2024 A | 200 243 | 0 | 0 | $0 |
| Thorpe W Mckenzie | Administrateur | 20 juin 2024 A | 2 597 471 | 0 | 0 | $0 |
| Daniel Vasella | Administrateur | 19 juin 2017 M | — | 0 | 0 | $0 |
| Fabrizio Bonanni | Administrateur | 19 juin 2017 M | — | 0 | 0 | $0 |
| BAY STREET FINANCIAL S.A. | Détenteur de 10% | 18 décembre 2020 S | 1 981 515 | 0 | 0 | $0 |
| Thomas Gut | Détenteur de 10% | 12 février 2020 D | 3 914 111 | 0 | 0 | $0 |
| Fondation Rennes | Détenteur de 10% | 3 février 2020 G | 110 282 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 4 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.